A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ER / enhancement ratio

[Related PubMed/MEDLINE]
Total Number of Papers: 160
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ER  (>> Co-occurring Abbreviation)
Long Form:   enhancement ratio
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Development of galangal essential oil-based microemulsion gel for transdermal delivery of flurbiprofen: simultaneous permeability evaluation of flurbiprofen and 1,8-cineole. FP, GEO, ME
2020 Quantitative Analysis of Lower Leg Muscle Enhancement Measured From Dynamic Computed Tomographic Angiography for Diagnosis of Peripheral Arterial Occlusive Disease. CV, dyn-CTA
2019 Accuracy of apparent diffusion coefficients and enhancement ratios on magnetic resonance imaging in differentiating primary cerebral lymphomas from glioblastoma. ADC, AUC, PCL
2019 Distinguishing soft tissue sarcomas of different histologic grades based on quantitative MR assessment of intratumoral heterogeneity. ROI, SI, STS
2019 Imaging Analysis of Ganglioneuroma and Quantitative Analysis of Paraspinal Ganglioneuroma. AER, AUCs, GN, HU, MGN, NPV, PPV, RGN, ROC, Se, Sp, VER
2019 Imaging of the Temporomandibular Joint in Juvenile Idiopathic Arthritis: How Does Quantitative Compare to Semiquantitative MRI Scoring? ICCs, JIA, MRI, OMERACT, TMJ
2019 Prognostic value of enhancement rate by enhanced ultrasound in hepatitis B virus-positive hepatocellular carcinoma undergoing radiofrequency ablation. CEUS, HCC, HR, RFA, TNM
2019 Prognostic Value of Quantitative Perfusion Parameters by Enhanced Ultrasound in Endometrial Cancer. CEUS, DFS, EI, OS, RT, TIC
2019 Skin Electrical Resistance Measurement of Oxygen-Containing Terpenes as Penetration Enhancers: Role of Stratum Corneum Lipids. ATR-FTIR, PEs, SC, SER
10  2019 The Relationship of Arterial Wall Enhancement Ratio on MRI with the Degree of Inflammation in a Rabbit Aneurysm Model: A Pilot Study. RCCA
11  2019 Ultrasmall superparamagnetic nanoparticles targeting E-selectin: synthesis and effects in mice in vitro and in vivo. MRI, NPC, PEG, sLeX, USPIO
12  2019 Wall enhancement ratio determined by vessel wall MRI associated with symptomatic intracranial aneurysms. AWE, HR-MRI, IAs
13  2019 [Effects of pungent essential oil from three Chinese herbs on percutaneous absorption of alkaloids from Sophorae Flavescentis Radix]. UPLC-TQ-MS
14  2018 Accelerated whole brain intracranial vessel wall imaging using black blood fast spin echo with compressed sensing (CS-SPACE). CR, ETL
15  2018 Can functional parameters from hepatobiliary phase of gadoxetate MRI predict clinical outcomes in patients with cirrhosis? AUC, CEI, CES, CES 20, CPS, ER 15, HE, MELD, MRI, VB
16  2018 Design and Development of Repaglinide Microemulsion Gel for Transdermal Delivery. RPG
17  2018 Facilitated permeation of insulin across TR146 cells by cholic acid derivatives-modified elastic bilosomes. SC, SC-lipo, SDGC, SDTC, SDTC-lipo, SGC, STC
18  2018 Wall enhancement ratio and partial wall enhancement on MRI associated with the rupture of intracranial aneurysms. HRMRI, IAs, PWE
19  2017 Clinical value of combining transvaginal contrast-enhanced ultrasonography with serum human epididymisprotein-4 and the resistance index for early-stage epithelial ovarian cancer. EOC, HE4, PI, RI, TIC, TVCEUS
20  2017 Development of essential oils as skin permeation enhancers: penetration enhancement effect and mechanism of action. ATR-FTIR, EOs, SC
21  2017 Development of phospholipid vesicle-based permeation assay models capable of evaluating percutaneous penetration enhancing effect. ATR-FTIR, LL, PE, PVPA, RB, SC, SL
23  2017 Enlargement Ratio May Predict Device Size in Elderly Patients with Atrial Septal Defect. ASDs, EA, TEE
24  2017 Exploring unsaturated fatty acid cholesteryl esters as transdermal permeation enhancers. Chol, Chol-LLA, CPEs, FAs, TEER, TNF, UFA
25  2017 High-Throughput Screening of Potential Skin Penetration-Enhancers Using Stratum Corneum Lipid Liposomes: Preliminary Evaluation for Different Concentrations of Ethanol. FL, HTS, SCLLs
26  2017 Is Intra-Articular Steroid Injection to the Temporomandibular Joint for Juvenile Idiopathic Arthritis More Effective and Efficient When Performed With Image Guidance? IASI, JIA, MIO, TMJ
27  2017 Lymphoma and inflammation in the orbit: Diagnostic performance with diffusion-weighted imaging and dynamic contrast-enhanced MRI. ADC, CI, DCE, DWI, MRI, WR
28  2017 Orbital malignant lesions in adults: multiparametric MR imaging. ADC, CI, DCE, ROC, WR
29  2017 The Effect and Mechanism of Transdermal Penetration Enhancement of Fu's Cupping Therapy: New Physical Penetration Technology for Transdermal Administration with Traditional Chinese Medicine (TCM) Characteristics. CPEs, FCT, FCTH, FCTL, FCTM, MRT, SC, SEM, TCM, TEM
30  2017 Time dependence of the enhancement effect of chemical enhancers: Molecular mechanisms of enhancing kinetics. AZ, CLSM, SC, TDDS
31  2017 Transdermal agomelatine microemulsion gel: pyramidal screening, statistical optimization and in vivo bioavailability. ---
32  2017 Transdermal delivery of dimethyl fumarate for Alzheimer's disease: Effect of penetration enhancers. AD, Cin, DMF, NMP, PG, TC, Terp
33  2017 Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapy. CE-T1WI, HCC, LS, MRE, RE, TACE/RFA, TS
34  2017 Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction. ADC, AUC, DWI, eTV, FLs, ICC, MM, sFF, WB-MRI
35  2017 [In vivo transdermal penetration enhancing activity of essential oil from Zanthoxyli Pericarpium by using microdialysis technique]. ---
36  2016 Assessment of Semiquantitative Parameters of Dynamic Contrast-Enhanced Perfusion MR Imaging in Differentiation of Subtypes of Renal Cell Carcinoma. DCE, RCC, TIC, WR
37  2016 Enhancement of Mycophenolate Mofetil Permeation for Topical Use by Eucalyptol and N-Methyl-2-pyrrolidone. EUL, MMF, MPA, NMP, USFDA
38  2016 Getting Beyond Impressions: An Evaluation of Engagement with Breast Cancer-related Facebook Content. CDC
39  2016 Hepatocellular carcinoma: IVIM diffusion quantification for prediction of tumor necrosis compared to enhancement ratios. ADC, DW, HCC, IVIM, PF
40  2016 High resolution imaging of the intracranial vessel wall at 3 and 7T using 3D fast spin echo MRI. SPACE
41  2016 Neuroendocrine liver metastases: Value of apparent diffusion coefficient and enhancement ratios for characterization of histopathologic grade. ADC, CE-T1WI, DWI, min, NETLM
42  2016 Quantifying Temporomandibular Joint Synovitis in Children With Juvenile Idiopathic Arthritis. JIA, MRIs, ROIs, TMJs
43  2016 Quantifying the Effect of Temporomandibular Joint Intra-Articular Steroid Injection on Synovial Enhancement in Juvenile Idiopathic Arthritis. IASIs, JIA, MIO, MRI, TMJ
44  2016 The Use of Breast Magnetic Resonance Imaging Parameters to Identify Possible Signaling Pathways of a Serum Biomarker, HE4. HE4, MRI, S-WI, S-WO, TTP
45  2016 [Comparison of essential oil from Mentha haplocalyx and menthol used as penetration enhancers]. FTIR, SC, TCM
46  2015 Comparative anti-inflammatory potential of crystalline and amorphous nano curcumin in topical drug delivery. CrysCur, TEM
47  2015 Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid. DP, Gd-DTPA, Gd-EOB-DTPA, HP, MRI, VP
48  2015 Effect of different polymers on in vitro and ex vivo permeability of Ofloxacin from its mucoadhesive suspensions. Papp
49  2015 Evaluation of femoral perfusion in a rabbit model of steroid-induced osteonecrosis by dynamic contrast-enhanced MRI with a high magnetic field MRI system. AUC, DCE-MRI, IS, mPSL
50  2015 Femoral perfusion after pulsed electromagnetic field stimulation in a steroid-induced osteonecrosis model. AUC, DCE-MRI, IS, PEMF
51  2015 Magnetic resonance imaging of the pancreas in streptozotocin-induced diabetic rats: Gadofluorine P and Gd-DOTA. MRI, SI, STZ
52  2015 MRI thresholds for discrimination between normal and mild temporomandibular joint involvement in juvenile idiopathic arthritis. SI, TMJ
53  2015 Optimizing signal intensity correction during evaluation of hepatic parenchymal enhancement on gadoxetate disodium-enhanced MRI: comparison of three methods. ER-SI, LL-TFE, MRI, SI
54  2015 [In vitro transdermal delivery of Qingfei Xiaocuo gel based on principal component analysis]. PCA
55  2014 In vitro & in vivo studies on lornoxicam loaded nanoemulsion gels for topical application. LX, TEM
56  2014 Initial experience of correlating parameters of intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging at 3.0T in nasopharyngeal carcinoma. DCE, DWI, EA, ICC, IVIM, MRI, MSI
57  2014 N-succinyl chitosan as buccal penetration enhancer for delivery of herbal agents in treatment of oral mucositis. ---
58  2014 Novel oleic acid derivatives enhance buccal permeation of didanosine. ddI, OA
59  2014 Preparation, characterization and stability study of dutasteride loaded nanoemulsion for treatment of benign prostatic hypertrophy. BPH
60  2014 Radiosensitization of pancreatic cancer cells by metformin through the AMPK pathway. ---
61  2014 Role of different biodegradable polymers on the permeability of ciprofloxacin. HPMC, Papp
62  2013 Comparison of Dynamic and Liver-Specific Gadoxetic Acid Contrast-Enhanced MRI versus Apparent Diffusion Coefficients. ADC, CR, HB
63  2013 Diagnostic accuracy of high-resolution MR enterography in Crohn's disease: comparison with surgical and pathological specimen. HR-MRE, ME
64  2013 Effect of lipophilicity on microneedle-mediated iontophoretic transdermal delivery across human skin in vitro. ITP, MN, PD
65  2013 Icaritin synergistically enhances the radiosensitivity of 4T1 breast cancer cells. CAM, CI, DRI, ICT, IR
66  2013 Intrahepatic periportal high intensity on hepatobiliary phase images of Gd-EOB-DTPA-enhanced MRI: imaging findings and prevalence in various hepatobiliary diseases. EOB-MRI, PHI
67  2013 Microemulsion as a tool for the transdermal delivery of ondansetron for the treatment of chemotherapy induced nausea and vomiting. CINV, ME, OCG
68  2013 Penetration effect of ostrich oil as a promising vehicle on transdermal delivery of sinomenine. ---
69  2013 Structure activity relationships in alkylammonium C12-gemini surfactants used as dermal permeation enhancers. ---
70  2012 A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl. HDF, HEK, PG, SEM
71  2012 Enantioselective penetration enhancing effect of carvone on the in vitro transdermal permeation of nicorandil. SC
72  2012 Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity. CAS, DCE-MRI, EOMs, GO, maxER, maxWR, SI, WR
73  2012 Quantification techniques to minimize the effects of native T1 variation and B1 inhomogeneity in dynamic contrast-enhanced MRI of the breast at 3 T. SRSF
74  2011 Does the hepatocellular phase of gadobenate dimeglumine help to differentiate hepatocellular carcinoma in cirrhotic patients according to histological grade? CNR, HCC, HIPAA, MRI, ROC
75  2011 Gadofluorine M-enhanced magnetic resonance imaging of inflammatory bowel disease: quantitative analysis and histologic correlation in a rat model. DNBS, Gd-DTPA, IBD, MR
76  2011 Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography. AMD, DA, GA, ICC, SD-OCT
77  2011 Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action. DSC, FT-IR, HCS
78  2010 B1 transmission-field inhomogeneity and enhancement ratio errors in dynamic contrast-enhanced MRI (DCE-MRI) of the breast at 3T. DCE-MRI
79  2010 Enhancement of percutaneous absorption of finasteride by cosolvents, cosurfactant and surfactants. ---
80  2010 Production, characterization, in vitro and ex vivo studies of babchi oil-encapsulated nanostructured solid lipid carriers produced by a hot aqueous titration method. ---
81  2010 Use of contrast enhancement and high-resolution 3D black-blood MRI to identify inflammation in atherosclerosis. MRI
82  2010 [Quantitative evaluation of Gd-EOB-DTPA uptake in phantom study for liver MRI]. FA, SI
83  2009 Crohn's disease lymphadenopathy: MR imaging findings. AI, FP, FS
84  2008 Basil oil is a promising skin penetration enhancer for transdermal delivery of labetolol hydrochloride. LHCl
85  2008 Design, synthesis, and radiosensitizing activities of sugar-hybrid hypoxic cell radiosensitizers. alpha-Man, beta-Gal, beta-GalNAc, beta-Glc
86  2008 Dynamic gadolinium-enhanced MRI in early ischaemia of the proximal femoral epiphysis--a preliminary study. ES, Gd, MRI, SE, WI
87  2008 Enhancement characteristics of cholangiocarcinomas on mutiphasic helical CT: emphasis on morphologic subtypes. HAP, PVP
88  2008 Studies on optimizing in vitro transdermal permeation of ondansetron hydrochloride using nerodilol, carvone, and limonene as penetration enhancers. HPC, TTS
89  2007 Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib. CXB
90  2007 Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride. CLSM
91  2006 Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin. CPEs, DIAPs, PSAs, ss
92  2006 In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser. ALA, CLSM, PDT, PpIX
93  2006 [Characteristics of vestibular-ocular reflex in guinea pigs during eccentric sinusoidal rotation]. VOR
94  2005 Biodegradable derivatives of tranexamic acid as transdermal permeation enhancers. TXA
95  2005 Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC. EGFR-TK, mAb, TCD50
96  2005 Discriminant analysis as a tool to identify compounds with potential as transdermal enhancers. HB
97  2004 Detection of hepatocellular carcinoma using double-echo FLASH sequence during the hepatic arterial phase. CNR, GRE, HCCs, MR, SNR
98  2001 Evaluation of derivatives of 3-(2-oxo-1-pyrrolidine)hexahydro-1H-azepine-2-one as dermal penetration enhancers: side chain length variation and molecular modeling. CL, HC, SC
99  2001 Late-phase enhancement of the upstream portion of pancreatic adenocarcinoma on dual-phase helical CT. CT
100  2001 Methylxanthine sensitization of human colon cancer cells to 186Re-labeled monoclonal antibody. CAF, MTXs, PTX